Table of Contents
Ugandan pharmaceutical tycoon Emmanuel Katongole’s stake in Cipla Quality Chemical Industries Limited (CiplaQCIL), a Kampala-based pharmaceutical manufacturing firm. is now worth UGX7.13 billion ($1.9 million), according to recent data compiled by Billionaires.Africa.
CiplaQCIL is a pharmaceutical manufacturing firm based in Luzira, a suburb of Kampala, Uganda’s capital city.
The company makes triple-combination antiretroviral drugs such as Lumartem, an antimalarial drug, and Texavir and Zentair, generic Hepatitis-B medications.
Emmanuel Katongole, the chairman of CiplaQCIL, owns a 2.79-percent equity stake in the Uganda-based pharmaceutical company, which translates to 101,933,042 ordinary shares in the company.
Aside from his stake in the company, Katongole also owns a beneficial interest in Vero Food Industries Limited and Tinosoft Limited, an IT company in Kampala.
The company’s total assets have surpassed $64 million under Katongole’s leadership, with retained earnings from operation well above $27 million, further solidifying its position as one of the most profitable pharmaceutical units in East Africa.
In its latest financial statement for the fiscal year ending March 31, 2022, CiplaQCIL reported a profit of Ush24.05 billion ($6.28 million), a significant improvement from the Ush10.54-billion ($2.9 million) loss reported in the previous year’s financial statement.
The increase in earnings was the result of management’s efficient cost-cutting strategies, which resulted in a reversal of impairment allowance totaling Ush20.2 billion ($5.23 million), despite a six-percent decrease in revenue from Ush284.54 billion ($74.6 million) to Ush267.43 billion ($70 million).
This impressive financial performance has materialized in a significant bump in its valuation with its share price increasing by 16.6 percent since the start of the year from Ush60 ($0.016) on Jan. 1 to Ush70 ($0.0187) at the time of drafting this report, thus pushing its market capitalization on the Uganda Stock Exchange closer to the $70-million mark.
In line with the recent valuation, the market value of Katongole’s stake in CiplaQCIL is presently worth Ush7.13 billion ($1.9 million), cementing his position as one of the wealthiest executives in Uganda.
The intelligence satisfies curiosity. The paid briefings satisfy strategy.
Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week's most consequential African wealth story - the kind of analysis that doesn't appear anywhere else.
Twice a month, a Wealth Intelligence brief profiles a single billionaire's holdings, cash flows and expansion pipeline in detail no public source matches.
→ Executive ($25/mo): Daily newsletter + Deep-Dive Reports
→ Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings
Subscribe now
